Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed) | PAR 18 714

Opportunity Information: Apply for PAR 18 714

The Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions is a National Institutes of Health (NIH) grant program designed to fund small-scale biomedical and behavioral research projects at colleges and universities that typically do not receive large amounts of NIH funding. The central idea is to strengthen research capacity at these institutions while giving students, especially undergraduates, meaningful opportunities to participate in real research. In practice, the program is meant to help faculty run focused, manageable projects that can be carried out in settings where research infrastructure and external funding may be more limited than at major research-intensive universities, while still advancing NIH-relevant science.

A key purpose of this opportunity is educational and institutional: it is not just about producing research results, but also about building a stronger research environment on campus and creating hands-on training experiences. The award emphasizes involving undergraduate students directly in the research process, which can include learning experimental design, data collection and analysis, responsible conduct of research, and scientific communication. By supporting research activity in undergraduate-focused settings, the program aims to increase student exposure to biomedical research careers and to strengthen the local culture of research and mentorship.

Eligibility is tightly tied to both degree offerings and NIH funding history. Applicant institutions must award baccalaureate degrees in the sciences and must not be substantially NIH-funded. Specifically, to qualify an institution needs to have received less than 6 million dollars per year in NIH support (measured in total costs) in at least 4 of the last 7 fiscal years. This rule is intended to ensure the program benefits institutions for which NIH funding is not already a dominant part of their research portfolio. The opportunity is open to both public/state-controlled institutions of higher education and private institutions of higher education, as long as they meet the AREA eligibility requirements.

The funding opportunity also highlights several categories of institutions that may apply if they meet the program rules, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), and Tribally Controlled Colleges and Universities (TCCUs). These categories are explicitly named as other eligible applicants, reinforcing the program’s role in broadening participation and supporting research training environments that serve diverse student populations.

The announcement is clear about restrictions related to foreign eligibility. Non-domestic (non-U.S.) entities, meaning foreign institutions, are not eligible to apply directly. In addition, non-domestic components of U.S. organizations are not eligible to apply as the applicant organization. However, foreign components, as defined in the NIH Grants Policy Statement, are allowed. In practical terms, that means the grant must be held by an eligible U.S. institution, but certain parts of the work may involve foreign components when justified and consistent with NIH policy.

This opportunity is an NIH discretionary grant mechanism and falls under the health funding activity category (CFDA number 93.859). The specific funding opportunity number is PAR-18-714, and it is an R15 mechanism with the condition “Clinical Trial Not Allowed,” meaning the proposed project cannot be a clinical trial under NIH definitions. The award ceiling listed is 300,000 dollars, indicating an upper limit on the amount of funding expected per award under this announcement. The original closing date referenced in the source information is 2021-05-07, and the posting creation date is 2018-03-14, which helps place the opportunity in time for applicants checking whether newer reissues or related notices have replaced or extended it.

Overall, this AREA R15 opportunity is best understood as a way for undergraduate-focused, NIH-light institutions to compete for federal research support that is intentionally scaled to their environment. It is designed to simultaneously advance a specific research question and to expand research experiences for undergraduates, while strengthening the institution’s longer-term ability to sustain research activity. For exact requirements and definitions, the notice emphasizes consulting the full funding opportunity and NIH policy documents for eligibility details and how terms like “foreign component” and “clinical trial” are applied.

• The National Institutes of Health in the health sector is offering a public funding opportunity titled "Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.859.
• This funding opportunity was created on 2018-03-14.
• Applicants must submit their applications by 2021-05-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Each selected applicant is eligible to receive up to $300,000.00 in funding.
• Eligible applicants include: Public and State controlled institutions of higher education, Private institutions of higher education, Others.

Apply for PAR 18 714

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: